Nearly 90,000 bottles of children’s ibuprofen recalled nationwide due to contamination concerns, FDA says
Nearly 90,000 bottles of children’s ibuprofen oral suspension have been recalled nationwide due to contamination concerns, according to the U.S. Food and Drug Administration.
The recall involves Children’s Ibuprofen Oral Suspension, USP, 100 mg per 5 mL, packaged in 4-fluid-ounce bottles and manufactured for Taro Pharmaceuticals U.S.A., Inc.
The recall was initiated after the company received complaints about a gel-like mass and black particles found in the product, the FDA said.
A total of 89,592 bottles are included in the recall. The affected lots are 7261973A and 7261974A, with an expiration date of Jan. 31, 2027.
The medication was distributed nationwide.
The recall, initiated March 2 by Strides Pharma Inc. of Bridgewater Township, was classified as a Class II recall on March 16, meaning the product may cause temporary or medically reversible adverse health consequences.
The FDA said the recall remains ongoing.
